Dr Christine Houghton returns to FX Medicine to discuss sulforaphane, its’ benefits and uses for various conditions, and why we should change the way we think about probiotics, antioxidants, and the overall way in which we approach treating our patients.
Naturopath and Nutritionist Kate Holm discusses the differences around case tasking, dosing of supplements and herbal remedies, and pathology testing in children.
Paying attention to diet and a health gut microbiome is often overlooked in addressing mental health and yet, evidence shows these aspects are crucial....
Dr Isaac Eliaz discusses how Galectin-3 is implicated in disease development, as well as the research and ramifications of using modfied citrus protein in the treatment of various disease states, including sepsis, cancer, and autoimmunity.
A look at the first study to evaluate tubulin as a target of curcumin against Giardia trophozoites.
Recent research explored whether there is a relationship between proton pump inhibitor (PPI) use in irritable bowel syndrome (IBS) and small intestinal bacterial overgrowth (SIBO).
It is estimated that the global prevalence of IBS is 11%. The most common cause of IBS is small intestinal bacterial overgrowth (SIBO) — in fact, a whopping 60-80% of IBS is due to this common condition, totalling a possible 500 million people worldwide.
What are the differences in gut bacteria from an obese person to a lean person? Scientists are starting to explore this further.
